INVITRO AND INVIVO TESTING AND CORRELATION FOR ORAL CONTROLLED MODIFIED-RELEASE DOSAGE FORMS

被引：74
|
作者：
SKELLY, JP
AMIDON, GL
BARR, WH
BENET, LZ
CARTER, JE
ROBINSON, JR
SHAH, VP
YACOBI, A
机构：
[1] JANSSEN PHARMACEUT INC,PISCATAWAY,NJ 08854
[2] UNIV WISCONSIN,SCH PHARM,MADISON,WI 53706
[3] UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109
[4] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298
[5] AMER CYANAMID CO,PEARL RIVER,NY 10965
[6] UNIV CALIF SAN FRANCISCO,SCH PHARM S926,SAN FRANCISCO,CA 94143
来源：
PHARMACEUTICAL RESEARCH | 1990年 / 7卷 / 09期
关键词：
D O I：
10.1023/A:1015970512368
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
下载
收藏
页码：975 / 982
页数：8
相关论文
共 50 条
  • [41] IBUPROFEN DELAYED RELEASE DOSAGE FORMS - A PROPOSAL FOR THE PREPARATION OF AN INVITRO INVIVO PULSATILE SYSTEM
    CONTE, U
    GIUNCHEDI, P
    MAGGI, L
    SANGALLI, ME
    GAZZANIGA, A
    COLOMBO, P
    LAMANNA, A
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1992, 38 (06) : 209 - 212
  • [42] Extrusion and spheronization in the development of oral controlled-release dosage forms
    Gandhi, R
    Kaul, CL
    Panchagnula, R
    PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (04): : 160 - 170
  • [43] INVITRO EVALUATION OF MODIFIED STARCHES AS MATRICES FOR SUSTAINED-RELEASE DOSAGE FORMS
    VANAERDE, P
    REMON, JP
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 45 (1-2) : 145 - 152
  • [44] COMPARATIVE BIOAVAILABILITY OF ORAL DOSAGE FORMS OF OXAZEPAM - CORRELATION WITH INVITRO DISSOLUTION RATE
    PILBRANT, A
    GLENNE, PO
    SUNDWALL, A
    VESSMAN, J
    WRETLIND, M
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1977, 40 : 7 - 15
  • [45] CARBAMAZEPINE MODIFIED RELEASE DOSAGE FORMS
    GIUNCHEDI, P
    CONTE, U
    LAMANNA, A
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (13) : 1753 - 1764
  • [46] INVIVO EVALUATION OF A THEOPHYLLINE ORAL CONTROLLED-RELEASE UNIT DOSAGE FORM
    GANGADHARAN, B
    RITSCHEL, WA
    HUSSAIN, SA
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1987, 37-2 (11): : 1256 - 1257
  • [47] GASTROINTESTINAL BIOAVAILABILITY - DETERMINATION OF INVIVO RELEASE PROFILES OF SOLID ORAL DOSAGE FORMS BY DECONVOLUTION
    GILLESPIE, WR
    VENGPEDERSEN, P
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1985, 6 (03) : 351 - 355
  • [48] INVITRO AND INVIVO DISSOLUTION OF RECTAL INDOMETHACIN DOSAGE FORMS
    MOLLER, H
    PHARMAZEUTISCHE INDUSTRIE, 1984, 46 (05): : 514 - 520
  • [49] MICROBIAL TESTING OF ORAL DOSAGE FORMS
    SCHNELLER, GH
    DRUG & COSMETIC INDUSTRY, 1978, 122 (02): : 48 - &
  • [50] INVITRO AND INVIVO STUDIES OF SUSTAINED-RELEASE FLOATING DOSAGE FORMS CONTAINING SALBUTAMOL SULFATE
    BABU, VBM
    KHAR, RK
    PHARMAZIE, 1990, 45 (04): : 268 - 270
12345